Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders
Details for Australian Patent Application No. 2002312499 (hide)
International Classifications
Event Publications
2 January 2003 Complete Application Filed
Priority application(s): 60/298,594 14.06.01 US; 10/172,805 13.06.02 US
15 May 2003 Application Open to Public Inspection
Published as AU-B-2002312499
15 January 2004 Amendment Made
The nature of the amendment is: Amend the invention title to read Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders.
19 April 2007 Application Accepted
Published as AU-B-2002312499
16 August 2007 Standard Patent Sealed
30 August 2007 Corrigenda
Applications Accepted - Name Index Under the name Protherics Salt Lake City, Inc., application no. 2002312499, under INID (54), correct the title to read Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002312500-SOCKET FOR SEMICONDUCTOR PACKAGE
2002312498-METHODS AND SYSTEMS FOR SENDING SIDE-CHANNEL DATA DURING DATA INACTIVE PERIOD
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser